PDCD1 and cancer: With a glimpse at the recent advances of ICB, the combination paradigms between traditional cancer treatment modalities (e.g., radiotherapy, photodynamic therapy, photothermal therapy and sonodynamic therapy (SDT)) and PD-1/PD-L1 or CTLA-4 can improve the effects of cancer immunotherapy.